AddLife Investor Relations Material
Latest events
Q1 2025
AddLife
Access the full event backlog
Slides, Transcripts, and Reports from 13,000 public companies
Latest reports from AddLife
Access all reports
AddLife AB, provides equipment, medical devices, and reagents primarily to healthcare system, research, colleges, and universities, as well as the food and pharmaceutical industries. AddLife's products are used in the development of cell therapies: cellular immunotherapy for autoimmune disease at institutions such as Scripps Research Institute Florida; clinical translation for Dystrophin gene therapy by partners such as Nationwide Children's Hospital; and phenotyping services for clinical researchers at Rush University Medical Center. It also offers products for biopharmaceutical development, including cell sorters from Abacus Biosystems; high-content screening plates for use in the drug discovery process; and automated microscope slide stainer products for automated image analysis and high content analysis. The company is based in Stockholm, Sweden.
Key slides for AddLife
Latest articles
)
D. E. Shaw & Co: Inside the Quiet Giant of Quant Finance
A deep dive into D. E. Shaw's evolution from a $28M quant startup to a $65B hedge fund giant, built on research, computing, and quiet consistency.
2 Jul 2025
)
Pershing Square Capital Management: Conviction, Reinvention, and Contrarian Investing
Pershing Square Capital Management has grown into a top-tier hedge fund through reinvention, conviction, and focus on long-term value creation.
2 Jul 2025
)
Eli Lilly: The Pharma Giant Behind Mounjaro and Zepbound
Eli Lilly's journey from insulin pioneer to global pharma giant, leading innovation in diabetes, obesity, and the future of metabolic health.
30 Jun 2025
Ticker symbol
ALIF
Country
🇸🇪 Sweden